Every material Form 8-K My Size, Inc. has filed with the SEC since August 28, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On September 15, 2026, My Size agreed to sell up to 1,308,901 shares of common stock, or pre-funded warrants in their place, at $1.91 each, along with Series C and Series D warrants, in a private placement expected to bring in about $2.5 million in gross proceeds before fees. The warrants are exercisable at $1.66 per share, so the deal would add up to roughly 2.6 million potential shares to the share count, which dilutes existing shareholders, and the company says the proceeds will go to general corporate purposes, including working capital.
Up to 1,308,901 shares or pre-funded warrants at $1.91 each; gross proceeds of about $2.5 million before placement agent fees and expenses
Series C and Series D warrants, each for up to 1,308,901 shares, exercisable immediately at $1.66 per share; Series C term is five years and Series D term is 18 months from the resale registration effective date
H.C. Wainwright & Co. is exclusive placement agent, with a 7% cash placement fee, a 1.0% management fee and placement agent warrants for 91,623 shares at $2.3875
Offering expected to close on or about September 16, 2026; company must file a resale registration statement within 15 days of signing and is barred from variable rate transactions for one year after the effective date
My Size, Inc. received a Nasdaq letter on August 25, 2026, saying its stockholders' equity of $2,347,000 as of June 30, 2026 fell short of the $2,500,000 minimum for continued listing. The letter has no immediate effect on the listing, but the company must submit a compliance plan by October 9, 2026, and the Staff may grant an extension through February 21, 2027 if the plan is accepted.
Reported stockholders' equity as of June 30, 2026: $2,347,000 versus a $2,500,000 minimum under Nasdaq Listing Rule 5550(b)(1)
Compliance plan due October 9, 2026; the company plans to submit it on time
If accepted, extension possible through February 21, 2027; if not accepted or compliance is not regained, Staff would issue a delisting determination, which a hearing request would stay
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every My Size, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →